JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1976) 70, 25-30       DOI: 10.1677/joe.0.0700025
© 1976 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ECKSTEIN, B.
Right arrow Articles by GOLDHABER, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ECKSTEIN, B.
Right arrow Articles by GOLDHABER, G.

SUPPRESSION OF LUTEINIZING HORMONE RELEASE BY 5{alpha}-ANDROSTANE-3{alpha},17β-DIOL AND ITS 3β EPIMER IN IMMATURE OVARIECTOMIZED RATS

B. ECKSTEIN, S. YEHUD, J. SHANI and G. GOLDHABER

The effect of 5{alpha}-androstane-3{alpha},17β-diol, its 3β epimer and oestradiol benzoate on suppression of LH release after ovariectomy was studied in immature rats. At doses of 50 and 100 µg/100 g body weight/day the 3{alpha} compound suppressed LH release after ovariectomy to the same extent as 0·1 µg oestradiol benzoate/100 g/day. 3{alpha}-Androstanediol at a dose of 25 µg/100 g/day suppressed LH release only up to day 45 of life, while the same dose of the 3β epimer had no effect on LH suppression. The effect of 3β-androstanediol on inducing precocious vaginal opening was found to be mediated by the ovaries, since it was eliminated by ovariectomy. These results confirm our previous findings on the participation of androstanediol in the normal regulation of LH and in the mechanism of onset of puberty in the rat.







HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1976 by the Society for Endocrinology.